REPORT ID 3354

United States Recombinant Antibody Market Report 2017

Publish Date
13-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the United States Recombinant Antibody market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Recombinant Antibody in these regions, from 2012 to 2022 (forecast).

United States Recombinant Antibody market competition by top manufacturers/players, with Recombinant Antibody sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abnova
    Medix Biochemica
    GE Healthcare
    SinoBiological
    Bioventix
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Chimeric Antibody
    Humanized Antibody
    Full Human Antibody
    Single Chain Antibody
    Bispecific Antibody
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Scientific Research
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Recombinant Antibody Market Report 2017
1 Recombinant Antibody Overview
    1.1 Product Overview and Scope of Recombinant Antibody
    1.2 Classification of Recombinant Antibody by Product Category
        1.2.1 United States Recombinant Antibody Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Recombinant Antibody Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Chimeric Antibody
        1.2.4 Humanized Antibody
        1.2.5 Full Human Antibody
        1.2.6 Single Chain Antibody
        1.2.7 Bispecific Antibody
    1.3 United States Recombinant Antibody Market by Application/End Users
        1.3.1 United States Recombinant Antibody Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Scientific Research
        1.3.4 Others
    1.4 United States Recombinant Antibody Market by Region
        1.4.1 United States Recombinant Antibody Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Recombinant Antibody Status and Prospect (2012-2022)
        1.4.3 Southwest Recombinant Antibody Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Recombinant Antibody Status and Prospect (2012-2022)
        1.4.5 New England Recombinant Antibody Status and Prospect (2012-2022)
        1.4.6 The South Recombinant Antibody Status and Prospect (2012-2022)
        1.4.7 The Midwest Recombinant Antibody Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Recombinant Antibody (2012-2022)
        1.5.1 United States Recombinant Antibody Sales and Growth Rate (2012-2022)
        1.5.2 United States Recombinant Antibody Revenue and Growth Rate (2012-2022)

2 United States Recombinant Antibody Market Competition by Players/Suppliers
    2.1 United States Recombinant Antibody Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Recombinant Antibody Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Recombinant Antibody Average Price by Players/Suppliers (2012-2017)
    2.4 United States Recombinant Antibody Market Competitive Situation and Trends
        2.4.1 United States Recombinant Antibody Market Concentration Rate
        2.4.2 United States Recombinant Antibody Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Recombinant Antibody Manufacturing Base Distribution, Sales Area, Product Type

3 United States Recombinant Antibody Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Recombinant Antibody Sales and Market Share by Region (2012-2017)
    3.2 United States Recombinant Antibody Revenue and Market Share by Region (2012-2017)
    3.3 United States Recombinant Antibody Price by Region (2012-2017)

4 United States Recombinant Antibody Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Recombinant Antibody Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Recombinant Antibody Revenue and Market Share by Type (2012-2017)
    4.3 United States Recombinant Antibody Price by Type (2012-2017)
    4.4 United States Recombinant Antibody Sales Growth Rate by Type (2012-2017)

5 United States Recombinant Antibody Sales (Volume) by Application (2012-2017)
    5.1 United States Recombinant Antibody Sales and Market Share by Application (2012-2017)
    5.2 United States Recombinant Antibody Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Recombinant Antibody Players/Suppliers Profiles and Sales Data
    6.1 Abnova
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Recombinant Antibody Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abnova Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Medix Biochemica
        6.2.2 Recombinant Antibody Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Medix Biochemica Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GE Healthcare
        6.3.2 Recombinant Antibody Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GE Healthcare Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 SinoBiological
        6.4.2 Recombinant Antibody Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 SinoBiological Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Bioventix
        6.5.2 Recombinant Antibody Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bioventix Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    ...

7 Recombinant Antibody Manufacturing Cost Analysis
    7.1 Recombinant Antibody Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Recombinant Antibody

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Recombinant Antibody Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Recombinant Antibody Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Recombinant Antibody Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Recombinant Antibody Sales Volume Forecast by Type (2017-2022)
    11.3 United States Recombinant Antibody Sales Volume Forecast by Application (2017-2022)
    11.4 United States Recombinant Antibody Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer